Results 211 to 220 of about 47,011 (239)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance

Human Vaccines and Immunotherapeutics, 2023
exaly  

Subtype of HBsAg in Chile

Vox Sanguinis, 1982
openaire   +2 more sources

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

Journal of Clinical Virology, 2011
Michael Peter Manns, Markus Cornberg, Jerzy Jaroszewicz   +2 more
exaly  

HBsAg

2009
openaire   +1 more source

Subtypes of HBSAg in Oceania

2015
openaire   +2 more sources

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

Antiviral Research, 2012
Valeria Micheli, Carlo Federico Perno, Valentina Svicher   +2 more
exaly  

LIVER DISEASE IN HBsAg CARRIERS

The Lancet, 1982
T, Fernández-de-Sevilla, J M, Martínez-Vázquez, I, Ocaña, A, Ruibal, R, Bacardi   +4 more
openaire   +2 more sources

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo , hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection

Emerging Microbes and Infections, 2020
Luna Colagrossi, Upkar Gill, Arianna Battisti   +2 more
exaly  

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues

Journal of Hepatology, 2019
Chung Yan Grace Lui, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong   +2 more
exaly  

Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production

EBioMedicine, 2019
Juan Chen, Xiaojiong Jia, Wong V K W
exaly